Skip to main content
NCBI home page
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
. 1997 May;22(3):185–191.

Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls.

K M Lawrence 1, F De Paermentier 1, S Lowther 1, M R Crompton 1, C L Katona 1, R W Horton 1
PMCID: PMC1188851  PMID: 9183117

Abstract

Saturation binding of [3H]paroxetine was performed in 10 brain regions from a group of suicide victims who had a firm, retrospective diagnosis of depression and who had been prescribed antidepressant drugs, as well as in a group of controls. The number of binding sites did not differ significantly between suicide victims and controls, apart from in putamen, where a lower number of sites was found in the suicide victims. Higher dissociation constant (Kd) values were found in suicide victims dying by antidepressant overdose and also in those dying by other means when compared with controls.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arora R. C., Meltzer H. Y. Seasonal variation of imipramine binding in the blood platelets of normal controls and depressed patients. Biol Psychiatry. 1988 Feb 1;23(3):217–226. doi: 10.1016/0006-3223(88)90032-7. [DOI] [PubMed] [Google Scholar]
  2. Beskow J., Gottfries C. G., Roos B. E., Winblad B. Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group. Acta Psychiatr Scand. 1976 Jan;53(1):7–20. doi: 10.1111/j.1600-0447.1976.tb00054.x. [DOI] [PubMed] [Google Scholar]
  3. Braddock L. E., Cowen P. J., Elliott J. M., Fraser S., Stump K. Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline. Neuropharmacology. 1984 Feb;23(2B):285–286. doi: 10.1016/0028-3908(84)90073-x. [DOI] [PubMed] [Google Scholar]
  4. Brunello N., Riva M., Volterra A., Racagni G. Effect of some tricyclic and nontricyclic antidepressants on [3H]imipramine binding and serotonin uptake in rat cerebral cortex after prolonged treatment. Fundam Clin Pharmacol. 1987;1(5):327–333. doi: 10.1111/j.1472-8206.1987.tb00570.x. [DOI] [PubMed] [Google Scholar]
  5. Buchsbaum M. S., Wu J., DeLisi L. E., Holcomb H., Kessler R., Johnson J., King A. C., Hazlett E., Langston K., Post R. M. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord. 1986 Mar-Apr;10(2):137–152. doi: 10.1016/0165-0327(86)90036-4. [DOI] [PubMed] [Google Scholar]
  6. Cheetham S. C., Crompton M. R., Czudek C., Horton R. W., Katona C. L., Reynolds G. P. Serotonin concentrations and turnover in brains of depressed suicides. Brain Res. 1989 Nov 20;502(2):332–340. doi: 10.1016/0006-8993(89)90629-x. [DOI] [PubMed] [Google Scholar]
  7. Cheetham S. C., Crompton M. R., Katona C. L., Horton R. W. Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res. 1988 Mar 8;443(1-2):272–280. doi: 10.1016/0006-8993(88)91621-6. [DOI] [PubMed] [Google Scholar]
  8. Cheetham S. C., Viggers J. A., Slater N. A., Heal D. J., Buckett W. R. [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology. 1993 Aug;32(8):737–743. doi: 10.1016/0028-3908(93)90181-2. [DOI] [PubMed] [Google Scholar]
  9. Coppen A., Swade C., Wood K. Platelet 5-hydroxytryptamine accumulation in depressive illness. Clin Chim Acta. 1978 Jul 1;87(1):165–168. doi: 10.1016/0009-8981(78)90071-2. [DOI] [PubMed] [Google Scholar]
  10. Cowen P. J., Geaney D. P., Schächter M., Green A. R., Elliott J. M. Desipramine treatment in normal subjects. Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors. Arch Gen Psychiatry. 1986 Jan;43(1):61–67. doi: 10.1001/archpsyc.1986.01800010063008. [DOI] [PubMed] [Google Scholar]
  11. D'Hondt P., Maes M., Leysen J. E., Gommeren W., Scharpé S., Cosyns P. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification. J Affect Disord. 1994 Sep;32(1):27–35. doi: 10.1016/0165-0327(94)90058-2. [DOI] [PubMed] [Google Scholar]
  12. D'haenen H., De Waele M., Leysen J. E. Platelet 3H-paroxetine binding in depressed patients. Psychiatry Res. 1988 Oct;26(1):11–17. doi: 10.1016/0165-1781(88)90082-0. [DOI] [PubMed] [Google Scholar]
  13. Ferrier I. N., McKeith I. G., Cross A. J., Perry E. K., Candy J. M., Perry R. H. Postmortem neurochemical studies in depression. Ann N Y Acad Sci. 1986;487:128–142. doi: 10.1111/j.1749-6632.1986.tb27893.x. [DOI] [PubMed] [Google Scholar]
  14. Gleiter C. H., Nutt D. J. Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes. Psychopharmacology (Berl) 1988;95(1):68–70. doi: 10.1007/BF00212769. [DOI] [PubMed] [Google Scholar]
  15. Graham D., Tahraoui L., Langer S. Z. Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat. Neuropharmacology. 1987 Aug;26(8):1087–1092. doi: 10.1016/0028-3908(87)90252-8. [DOI] [PubMed] [Google Scholar]
  16. Healy D. T., Paykel E. S., Whitehouse A. M., White W., Wilton-Cox H., Johnson A. L., Theodorou A. E., Lawrence K., Horton R. W. Platelet [3H]imipramine and alpha 2-adrenoceptor binding in normal subjects during desipramine administration and withdrawal. Neuropsychopharmacology. 1991 Feb;4(2):117–124. [PubMed] [Google Scholar]
  17. Healy D., Theodorou A. E., Whitehouse A. M., Lawrence K. M., White W., Wilton-Cox H., Kerry S. M., Horton R. W., Paykel E. S. 3H-imipramine binding to previously frozen platelet membranes from depressed patients, before and after treatment. Br J Psychiatry. 1990 Aug;157:208–215. doi: 10.1192/bjp.157.2.208. [DOI] [PubMed] [Google Scholar]
  18. Hrdina P. D., Bakish D., Chudzik J., Ravindran A., Lapierre Y. D. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci. 1995 Jan;20(1):11–19. [PMC free article] [PubMed] [Google Scholar]
  19. Hrdina P. D., Demeter E., Vu T. B., Sótónyi P., Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 1993 Jun 18;614(1-2):37–44. doi: 10.1016/0006-8993(93)91015-k. [DOI] [PubMed] [Google Scholar]
  20. Hrdina P. D. Differentiation of two components of specific [3H]imipramine binding in rat brain. Eur J Pharmacol. 1984 Jul 20;102(3-4):481–488. doi: 10.1016/0014-2999(84)90569-7. [DOI] [PubMed] [Google Scholar]
  21. Husain M. M., McDonald W. M., Doraiswamy P. M., Figiel G. S., Na C., Escalona P. R., Boyko O. B., Nemeroff C. B., Krishnan K. R. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res. 1991 Oct;40(2):95–99. doi: 10.1016/0925-4927(91)90001-7. [DOI] [PubMed] [Google Scholar]
  22. Iny L. J., Pecknold J., Suranyi-Cadotte B. E., Bernier B., Luthe L., Nair N. P., Meaney M. J. Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets. Biol Psychiatry. 1994 Sep 1;36(5):281–291. doi: 10.1016/0006-3223(94)90625-4. [DOI] [PubMed] [Google Scholar]
  23. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  24. Lawrence K. M., De Paermentier F., Cheetham S. C., Crompton M. R., Katona C. L., Horton R. W. Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain Res. 1990 Aug 27;526(1):17–22. doi: 10.1016/0006-8993(90)90244-6. [DOI] [PubMed] [Google Scholar]
  25. Lawrence K. M., Falkowski J., Jacobson R. R., Horton R. W. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine. Psychopharmacology (Berl) 1993;110(1-2):235–239. doi: 10.1007/BF02246979. [DOI] [PubMed] [Google Scholar]
  26. Lawrence K. M., Katona C. L., Abou-Saleh M. T., Robertson M. M., Nairac B. L., Edwards D. R., Lock T., Burns R. A., Harrison D. A., Horton R. W. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine. Psychopharmacology (Berl) 1994 Jun;115(1-2):261–264. doi: 10.1007/BF02244781. [DOI] [PubMed] [Google Scholar]
  27. Lesch K. P., Aulakh C. S., Wolozin B. L., Tolliver T. J., Hill J. L., Murphy D. L. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res Mol Brain Res. 1993 Jan;17(1-2):31–35. doi: 10.1016/0169-328x(93)90069-2. [DOI] [PubMed] [Google Scholar]
  28. Meltzer H. Y., Arora R. C., Baber R., Tricou B. J. Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry. 1981 Dec;38(12):1322–1326. doi: 10.1001/archpsyc.1981.01780370024002. [DOI] [PubMed] [Google Scholar]
  29. Nankai M., Yamada S., Yoshimoto S., Watanabe A., Mori H., Asai K., Toru M. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age. Psychiatry Res. 1994 Feb;51(2):147–155. doi: 10.1016/0165-1781(94)90034-5. [DOI] [PubMed] [Google Scholar]
  30. Nelson E. C., Sheline Y. I., Bardgett M. E., Jackson J. L., Csernansky J. G. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder. Psychiatry Res. 1995 Sep 29;58(2):117–125. doi: 10.1016/0165-1781(95)02695-s. [DOI] [PubMed] [Google Scholar]
  31. Raisman R., Briley M. S., Langer S. Z. Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding. Eur J Pharmacol. 1980 Feb;61(4):373–380. doi: 10.1016/0014-2999(80)90076-x. [DOI] [PubMed] [Google Scholar]
  32. Suranyi-Cadotte B. E., Quirion R., Nair N. P., Lafaille F., Schwartz G. Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients. Life Sci. 1985 Feb 25;36(8):795–799. doi: 10.1016/0024-3205(85)90201-2. [DOI] [PubMed] [Google Scholar]
  33. Tuomisto J., Tukiainen E., Ahlfors U. G. Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology (Berl) 1979 Oct;65(2):141–147. doi: 10.1007/BF00433040. [DOI] [PubMed] [Google Scholar]
  34. Wägner A., Aberg-Wistedt A., Asberg M., Bertilsson L., Mårtensson B., Montero D. Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder. Arch Gen Psychiatry. 1987 Oct;44(10):870–877. doi: 10.1001/archpsyc.1987.01800220032006. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Medical Association

RESOURCES